Impact of Aneuploidy and Chromosome 9p Loss on Tumor Immune Microenvironment and ICI Efficacy in NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of aneuploidy and chromosome 9p loss on tumor immune microenvironment and immune checkpoint inhibitor efficacy in non-small cell lung cancer
J Thorac Oncol 2023 May 27;[EPub Ahead of Print], JV Alessi, X Wang, A Elkrief, B Ricciuti, YY Li, H Gupta, LF Spurr, H Rizvi, J Luo, F Pecci, G Lamberti, G Recondo, D Venkatraman, A Di Federico, MM Gandhi, VR Vaz, M Nishino, LM Sholl, AD Cherniack, M Ladanyi, A Price, AL Richards, M Donoghue, J Lindsay, B Sharma, MM Turner, KL Pfaff, KD Felt, SJ Rodig, X Lin, ML Meyerson, BE Johnson, DC Christiani, AJ Schoenfeld, MM AwadFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.